Publication | Closed Access
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
97
Citations
13
References
2003
Year
Rituximab appears to be a promising immunotherapeutic agent for the treatment of autoimmune thrombocytopenias.
| Year | Citations | |
|---|---|---|
Page 1
Page 1